EU clinical trial harmonisation pilot expands scope
This article was originally published in Scrip
Companies planning to undertake multinational clinical trials in just three or more European Union member states are now eligible to participate in the voluntary harmonisation procedure, the pilot programme initiated by the Heads of Medicines Agencies Clinical Trials Facilitation Group that offers co-ordinated and simultaneous review of clinical trial applications.
You may also be interested in...
Based on the operational experience gained using the new international standard for reporting suspected adverse reactions in EudraVigilance, the EU has decided to set a date for its mandatory use.
The UK’s Health Research Authority has agreed in principle to implement a new policy that aims to drive a lasting change in clinical trial transparency. Not everyone is convinced.
The UK scheme allows patients with early access to promising new unlicensed medicines when there is a clear unmet medical need.